Micro RNA 146a gene variant / TNF-α / IL-6 / IL-1 β; A cross-link axis inbetween oxidative stress, endothelial dysfunction and neuro-inflammation in acute ischemic stroke and chronic schizophrenic patients
Graphical abstract
Introduction
Schizophrenia is a chronic crushing mental disorder that is presented mainly by positive, negative and cognitive symptoms [1,2]. Its clinical course is usually characterized by recurrent relapses that cause an additional burden on cognitive performance, treatment response, and psychosocial functions [3]. The chronicity of schizophrenia and its drug-resistant course may also favor some neurodegenerative processes, although the proof of neuronal death in schizophrenia is highly controversial [4]. Chronic schizophrenic patients were approved to have two to three times' higher risk of premature death than general population, with life expectancy decrement of 15–20 years. Basically, acute ischemic stroke (AIS) includes brain blood flow obstruction with irreversible brain damage, is considered one of the main causative leading agents of schizophrenic patients premature death [5]. Despite the great controversy in schizophrenia pathogenesis and its role in AIS incidence, few studies have established an association between environmental-genetic deregulations, neuro-inflammation, thrombosis, oxidative stress and this illness [6]. The principal underlying cause of AIS is vascular thromboembolic occlusion [7]. Importantly, endothelial-generated anti- and pro-coagulant residues are un-equivalently distributed throughout the vascular bed. Endothelial cells exerts an anticoagulant activity by expressing tissue factor pathway inhibitor, like thrombomodulin (TM) which binds thrombin and promotes protein C and thrombin activated fibrinolysis inhibitor (TAFI) segmentation, thereby obstacles coagulation and inducing fibrinolysis [8]. Even though, endothelial cells also show a procoagulant activity, as it manufactures plasminogen activator inhibitor (PAI-1), the main physiological inhibitor of tissue plasminogen activator (tPA) [9]. PAI-1 causes inactivation of urokinase plasminogen activator (uPA) that regulates the production of plasmin [10]. In addition, increased levels of PAI-1 have been recognized as a hallmark of endothelial dysfunction [11]. Bleeding or hypercoagulability and thrombosis may occur as a result of acquired alterations in the dynamic balance in vascular pathophysiology [12]. MicroRNAs (miRNAs) are one of the main eukaryotic genetic modulators that have been approved to be responsible for regulation of many cellular pathways. Alteration in circulating miRNAs levels has been documented to be intimately associated with incidence of many different human diseases, such as type 2 diabetes, cerebral stroke, neuropsychiatric disorders and immunological diseases [[13], [14], [15]]. Recently, hsa-miR-146a was identified as a potential diagnostic biomarker in various diseases with its gene located on the long arm of chromosome 5 (5q 33.3) with about 109 bases length (via NCBI) [16]. Cytokines are immune/inflammatory protein modulators that act as chemical messengers between immune cells modify the neurotransmitters and neuro-endocrine hormones metabolism, thus affecting neural development and behavioral changes [17]. Interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α are a group of proinflammatory cytokines which have been indulged as a cardinal axis of a common pathway of AIS incidence and schizophrenia liability factors. Its production and signaling are intimately regulated by a various genes that may be accused for schizophrenia [18]. Oxidative stress has hazardous damaging effects on different cellular components and causes DNA damage with subsequent formation of 8-hydroxy-2' -deoxyguanosine (8-OHdG) that has been largely used as a biomarker for oxidative stress DNA damage [19]. This study was undertaken to investigate the possible contribution of rs2910164 hsa-miR-146a C>G gene single nucleotide polymorphism to the molecular pathogenesis of schizophrenia and highlights their relation with neuro-inflammatory, endothelial dysfunction and oxidative stress pathways as AIS risk factors in patients with chronic schizophrenia.
Section snippets
Subjects
This prospective cross-sectional study was carried out in the Medical Biochemistry and Neuropsychiatry Departments, Faculty of Medicine, Tanta University. This study was conducted on 450 adult males aged 45–60 years. Uncooperative participants and those with hypertension, diabetes mellitus, renal diseases, malignancy, adrenal diseases, liver dysfunction, allergy, lipid or carbohydrate metabolic inborn disorders, peripheral vascular disease, cardiac dysfunction, head injuries history, recent
Results
Clinical and demographic characteristics of the studied groups: are shown in Table 1. No statistically significant difference was detected between the studied groups regarding age, number of hospitalization, duration of schizophrenia by years and BMI. The history of diabetes type 2, hypertension and smoking are significantly different across groups and particularly high in SZ with AIS. The lipid profile, carotid intima media thickness (cIMT) and atherogenic index (AI) were statistically
Discussion
In the present study, we initially compared the distribution of rs2910164 hsa miR-146aSNP between Egyptian schizophrenic patients with and without AIS and healthy controls to investigate a potential association of this mir-146a SNP with both schizophrenia and AIS susceptibility in those patients. Our preliminary data revealed increased frequencies (%) of the variant genotypes (CG+GG) in schizophrenic patients with AIS compared to schizophrenic patients without AIS and controls. Concomitantly,
Funding
This research did not receive any specific grant from funding agencies in the public, Commercial or not for profit sectors.
Declaration of competing interest
The authors declare that they have no conflict of interests.
Acknowledgment
We would like to acknowledge Dr. Rasha Lotfy, Radiology Department, Faculty of Medicine, Tanta University, for her valuable help in the Doppler Ultrasonography, Carotid intima media thickness (cIMT), computed tomography (CT) scan and Echocardiograph (ECG) that were done to all patients evaluation in the present work.
References (49)
- et al.
Meta-analysis of oxidative stress in schizophrenia
Biol. Psychiatry
(2013) - et al.
Associated illness severity in schizophrenia and diabetes mellitus: a systematic review
Psychiatry Res.
(2017) - et al.
Cognitive improvement in first-episode schizophrenia and healthy controls: a 6-year multi-assessment follow-up study
Psychiatry Res.
(2018) - et al.
Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and target for treatment
Blood
(2008) - et al.
Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia
Psychoneuroendocrinology
(2015) - et al.
Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs
Biol. Psychiatry
(2010) - et al.
Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: a cross-sectional study
Lipids Health Dis.
(2018) - et al.
Hyperlipidemia in patients with schizophrenia: a national population-based study
Gen. Hosp. Psychiatry
(2012) - et al.
The comparison of glycometabolism parameters and lipid profiles between drug-naive, first-episode schizophrenia patients and healthy controls
Schizophr. Res.
(2013) - et al.
Differential roles of TNFR1 and TNFR2 signaling in adult hippocampal neurogenesis
Brain Behav. Immun.
(2013)
Trafficking of Α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA) receptor subunit GluA2 from the endoplasmic reticulum is stimulated by a complex containing Ca2+/calmodulin-activated kinase II (CaMKII) and PICK1 protein and by release of Ca2+ from internal stores
J. Biol. Chem.
Neuronal-immune interactions in mediating stress effects in the etiology and course of schizophrenia: role of the amygdala in developmental co-ordination
Med. Hypotheses
Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia
Prog. Neuropsychopharmacol. Biol. Psychiatry
Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: a pivotal role of AMPK/SIRT1 and JAK2/STAT3/NF-κBsignalling pathway modulation
Toxicol. Appl. Pharmacol.
Tumor necrosis factor-alpha induces interleukin-6 production and integrin ligand expression by distinct transduction pathways
J. Biol. Chem.
MiR-146a regulates the TRAF6/TNF-axis in donor T cells during GVHD
Blood
Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms
Blood
Insight, cognitive dysfunction and symptomatology in schizophrenia
Eur. Arch. Psychiatry Clin. Neurosci.
Evaluation of short interval cortical inhibition and intracortical facilitation from the dorsolateral prefrontal cortex in patients with schizophrenia
Sci. Rep.
Neuroprotection in schizophrenia and its therapeutic implications
Psychiatr. Invest.
Thrombomodulin--a new target for treating stroke at the crossroad of coagulation and inflammation
Curr. Med. Chem.
Multiple roles of tissue plasminogen activator in schizophrenia pathophysiology
Semin. Thromb. Hemost.
Role of inflammation and its mediators in acute ischemic stroke
J. Cardiovasc. Transl. Res.
The endothelium in sepsis
Shock
Cited by (26)
Genetic Polymorphisms of Ischemic Stroke in Asians
2023, Clinica Chimica ActaMicroRNA schizophrenia: Etiology, biomarkers and therapeutic targets
2023, Neuroscience and Biobehavioral ReviewsmiR-146a and miR-200b alter cognition by targeting NMDA receptor subunits
2022, iScienceCitation Excerpt :In our previous study, we found miR-129-2, miR-148a, and miR-296 to be targeting NMDAR in vitro and in animal models in which NMDAR is dysregulated.16 In this study, we have investigated whether miR-146a and miR-200b, which are differentially expressed in diseases such as Alzheimer's disease and schizophrenia,17,18,19,20,21,22,23,24,25,26,27 can regulate NMDAR subunits. We established the interaction of these miRNAs with NMDAR subunits through online bioinformatic analysis followed by experimental approach using luciferase assay.
Changes and roles of IL-17A, VEGF-A and TNF-α in patients with cerebral infarction during the acute phase and early stage of recovery
2022, Clinical BiochemistryCitation Excerpt :The high expression of VEGF-A after cerebral infarction may be an important mechanism through which the body counteracts cerebral ischaemia, reduces brain injury, and promotes nerve repair [36,37]. Combined with earlier findings, our results suggest that TNF-α plays a complex role for a long time after cerebral infarction [8,38,39]. Elevated levels of serum IL-17A, VEGF-A and TNF-α can also be observed in several other diseases, such as myocardial infarction and various infections.